Mar. 12, 2020—Researchers from Vanderbilt-Ingram Cancer Center (VICC) discovered a role for MYCN in triple-negative breast cancer (TNBC), a particularly aggressive form of the disease, and identified a potential intervention for further clinical investigation.
Feb. 27, 2020—Researchers at VUMC are reporting another advance in the understanding and treatment of triple-negative breast cancer, which is particularly aggressive and difficult to treat.
Feb. 19, 2020—The two-year, $125,000 award will allow Marjan Rafat and her research group to investigate how radiation influences tumor and immune cell recruitment in triple negative breast cancer.
Oct. 17, 2019—A new study shows men with breast cancer are more likely to die than their female counterparts, across all stages of disease.
Oct. 8, 2019—Health Plus will promote breast cancer awareness at the VU Benefits Open House on Wednesday, Oct. 23.
Sep. 19, 2019—The Think Pink! Breast Cancer Awareness Expo is scheduled from 11 a.m. to 1 p.m. Wednesday, Oct. 2, in the Light Hall North Lobby. Visit the expo to learn about breast cancer prevention, screenings and more.
Jun. 26, 2019—Biomarkers of DNA methylation, which regulate gene expression, can be a predictor of breast cancer risk.
Mar. 25, 2019—The finding gives a boost to the field of metabolomics, the next big thing in fighting cancer. It can complement immunotherapies, which use the body’s natural defenses to kill cancer cells.